Methotrexate-related lymphoproliferative disorders in the liver: Case presentation and mini-review

doi:10.12998/wjcc.v7.i21.3553

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6985)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

633

WORD

245

HTML

2872

Figures (1-2)

348

Tables (1-4)

660

Sum=4758

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

876

Download

1351

Sum=2227

Nov 6, 2019 (publication date) through Feb 2, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Nov 6, 2019; 7(21): 3553-3561
Published online Nov 6, 2019. doi: 10.12998/wjcc.v7.i21.3553

Table 3 Characteristic of methotrexate related lymphoproliferative disorder

Characteristic of MTX-LPD
Potential association of EB virus
Treatment includes stopping the MTX and administering chemotherapy or performing surgery in some cases
By stopping MTX, about 30% of cases show improvement within a month
Chemotherapy includes R-CHP, R-THP-COP, etc. depending on the histological pattern

MTX-LPD: Methotrexate related lymphoproliferative disorder; EB: Epstein-Barr.

Citation: Mizusawa T, Kamimura K, Sato H, Suda T, Fukunari H, Hasegawa G, Shibata O, Morita S, Sakamaki A, Yokoyama J, Saito Y, Hori Y, Maruyama Y, Yoshimine F, Hoshi T, Morita S, Kanefuji T, Kobayashi M, Terai S. Methotrexate-related lymphoproliferative disorders in the liver: Case presentation and mini-review. World J Clin Cases 2019; 7(21): 3553-3561
URL: https://www.wjgnet.com/2307-8960/full/v7/i21/3553.htm
DOI: https://dx.doi.org/10.12998/wjcc.v7.i21.3553